Delivery Order SPE2DR25D3016-SPE2DR26FG1AE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $2,159.48 to AmerisourceBergen Drug Corp for IPOL Vial 5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. IPOL is an inactivated poliovirus vaccine commonly used in federal immunization programs and military healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,834.26 to AmerisourceBergen Drug Corp for IPOL vials (5 mL) on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. IPOL is an inactivated polio vaccine used by military and federal healthcare systems to support immunization...
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for IPOL vial 5ML, an inactivated polio vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of October 29, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for 5mL IPOL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. IPOL is an inactivated polio vaccine commonly used by the Department of Defense and other federal healthcare systems for immunization programs. This competitively awarded, non-set-aside contract reflects a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $17,441.60 to AmerisourceBergen Drug Corp for IPOL Vial 5ML, an inactivated polio vaccine product. Issued on April 24, 2025, with completion scheduled for April 25, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $106,898.18 to AmerisourceBergen Drug Corp for IPOL Vial 5ML pharmaceutical products. This firm fixed price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's Corporate Office facility located in Conshohocken, Pennsylvania, the company's headquarters and a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,690.60 by the Defense Logistics Agency for the supply of Ipol vial 5ml on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken facility. Ipol is an inactivated polio vaccine used within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML pharmaceutical product, with a ceiling value of $1,544.12. This competitive award, issued on September 14, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG1AEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,848.25 to AmerisourceBergen Drug Corp for IPOL vial 5ML on November 13, 2025, with completion targeted for November 14, 2025. This firm fixed price delivery order was not set-aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. IPOL is an inactivated poliovirus vaccine used across military and federal healthcare systems. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen demonstrates significant capacity to fulfill vaccines and immunological products through its comprehensive contract portfolio with DLA. The company's federal contract awards span a diverse range of pharmaceutical commodities including specialty medications, vaccines, and medical supplies across multiple therapeutic domains, positioning it as a critical vendor for DoD and other government healthcare systems requiring reliable pharmaceutical supply chain support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 11/13/25 |